Does POSACONAZOLE Cause Product use in unapproved indication? 661 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 661 reports of Product use in unapproved indication have been filed in association with POSACONAZOLE (POSACONAZOLE). This represents 11.4% of all adverse event reports for POSACONAZOLE.
661
Reports of Product use in unapproved indication with POSACONAZOLE
11.4%
of all POSACONAZOLE reports
49
Deaths
66
Hospitalizations
How Dangerous Is Product use in unapproved indication From POSACONAZOLE?
Of the 661 reports, 49 (7.4%) resulted in death, 66 (10.0%) required hospitalization, and 10 (1.5%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for POSACONAZOLE. However, 661 reports have been filed with the FAERS database.
What Other Side Effects Does POSACONAZOLE Cause?
Drug ineffective (785)
Off label use (430)
Drug interaction (383)
Death (369)
Condition aggravated (214)
Pyrexia (185)
Neutropenia (181)
Product use issue (181)
Febrile neutropenia (178)
Aspergillus infection (155)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which POSACONAZOLE Alternatives Have Lower Product use in unapproved indication Risk?
POSACONAZOLE vs POTASSIUM
POSACONAZOLE vs POTASSIUM, DIBASIC
POSACONAZOLE vs POTASSIUM IODIDE
POSACONAZOLE vs POTASSIUM, MONOBASIC
POSACONAZOLE vs POTASSIUM\SODIUM FLUORIDE